CORMEDIX INC. - COMMON
10.63
07-November-24 15:59:59
15 minutes delayed
Stocks
+0.31
+3.00%
Today's range
10.28 - 10.71
ISIN
N/A
Source
NASDAQ
-
CorMedix Inc. Announces Regulatory and Manufacturing Updates
08 Aug 2022 16:05:02 By Nasdaq GlobeNewswire
-
CorMedix to Participate at the JMP Securities Life Sciences Conference
08 Jun 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
12 May 2022 16:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Leadership Updates and Operational Changes
12 May 2022 08:30:01 By Nasdaq GlobeNewswire
-
03 May 2022 08:30:00 By Nasdaq GlobeNewswire
-
07 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
04 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
29 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCath
28 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
22 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces the Appointment of Chief Executive Officer
17 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
Cormedix Inc. Announces Resubmission of New Drug Application for DefenCath
28 Feb 2022 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix to Participate in Upcoming January Conferences
04 Jan 2022 08:00:02 By Nasdaq GlobeNewswire
-
CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
09 Nov 2021 16:05:02 By Nasdaq GlobeNewswire
-
02 Nov 2021 08:30:01 By Nasdaq GlobeNewswire
-
20 Oct 2021 08:30:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Executive Leadership Changes
04 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
CorMedix Inc. Announces Regulatory Update
07 Sep 2021 08:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
-
28 Jul 2021 08:30:00 By Nasdaq GlobeNewswire